{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:04:16Z","timestamp":1780560256490,"version":"3.54.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Nogra Pharma Ltd., Dublin, Ireland"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Background<\/jats:p>\n               <jats:p>Permanent chemotherapy-induced alopecia (pCIA), for which preventive interventions remain limited, can manifest with scarring. While the underlying pathomechanisms of pCIA are unclear, depletion of epithelial hair follicle (HF) stem cells (eHFSCs) is likely to play a role.<\/jats:p>\n               <jats:p>Objectives<\/jats:p>\n               <jats:p>To explore the hypothesis that, besides apoptosis, eHFSCs undergo pathological epithelial\u2013mesenchymal transition (EMT) in pCIA, thus explaining the scarring phenotype. Furthermore, we tested whether a peroxisome proliferator-activated receptor (PPAR)-\u03b3 modulator could prevent pCIA-associated pathomechanisms.<\/jats:p>\n               <jats:p>Methods<\/jats:p>\n               <jats:p>Organ-cultured human scalp HFs were treated with the cyclophosphamide metabolite 4-hydroperoxycyclophosphamide (4-HC). Additionally, HFs were pretreated with the agonistic PPAR-\u03b3 modulator N-acetyl-GED-0507-34-Levo (NAGED), which has previously been shown to promote K15 expression and antagonize EMT in eHFSCs.<\/jats:p>\n               <jats:p>Results<\/jats:p>\n               <jats:p>In accordance with anticipated hair bulb cytotoxicity, dystrophy and catagen induction, 4-HC promoted apoptosis along with increased p53 expression, DNA damage and pathological EMT in keratin 15+ (K15) eHFSCs, as evidenced by decreased E-cadherin expression and the appearance of fibronectin+ and vimentin+ cells in the hair bulge. Pretreatment with NAGED protected against 4-HC-induced hair bulb cytotoxicity\/dystrophy, and apoptosis, p53 upregulation and EMT in the bulge, thereby significantly preventing depletion of K15+ human eHFSCs ex vivo.<\/jats:p>\n               <jats:p>Conclusions<\/jats:p>\n               <jats:p>Since a key cyclophosphamide metabolite alone suffices to damage and deplete human scalp eHFSCs by promoting apoptosis, DNA damage and EMT ex vivo, strategies to prevent pCIA need to target these pathomechanisms. Given the ability of NAGED to prevent chemotherapy-induced eHFSCs damage ex vivo, our study introduces the stimulation of PPAR-\u03b3 signalling as a novel intervention strategy for the prevention of pCIA.<\/jats:p>","DOI":"10.1111\/bjd.20745","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T20:05:05Z","timestamp":1631131505000},"page":"129-141","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Peroxisome proliferator-activated receptor-\u03b3 signalling protects hair follicle stem cells from chemotherapy-induced apoptosis and epithelial\u2013mesenchymal transition"],"prefix":"10.1093","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1914-9035","authenticated-orcid":false,"given":"I.","family":"Piccini","sequence":"first","affiliation":[{"name":"Monasterium Laboratory M\u00fcnster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6327-5664","authenticated-orcid":false,"given":"L.","family":"Brunken","sequence":"additional","affiliation":[{"name":"Monasterium Laboratory M\u00fcnster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1901-0551","authenticated-orcid":false,"given":"J.","family":"Ch\u00e9ret","sequence":"additional","affiliation":[{"name":"Monasterium Laboratory M\u00fcnster Germany"},{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine Miami FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ghatak","sequence":"additional","affiliation":[{"name":"Monasterium Laboratory M\u00fcnster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-8385","authenticated-orcid":false,"given":"Y.","family":"Ramot","sequence":"additional","affiliation":[{"name":"The Faculty of Medicine Department of Dermatology Hadassah Medical Center, Hebrew University of Jerusalem Jerusalem Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5783-6605","authenticated-orcid":false,"given":"M.","family":"Alam","sequence":"additional","affiliation":[{"name":"Monasterium Laboratory M\u00fcnster Germany"},{"name":"Universidad Fernando Pessoa Canarias Las Palmas de Gran Canaria Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3735-7735","authenticated-orcid":false,"given":"T.S.","family":"Purba","sequence":"additional","affiliation":[{"name":"Centre for Dermatology Research University of Manchester, and NIHR Biomedical Research Centre Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1653-7908","authenticated-orcid":false,"given":"J.","family":"Hardman","sequence":"additional","affiliation":[{"name":"Centre for Dermatology Research University of Manchester, and NIHR Biomedical Research Centre Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2054-6428","authenticated-orcid":false,"given":"H.","family":"Erdmann","sequence":"additional","affiliation":[{"name":"Kosmed Klinik Hamburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Universidad Fernando Pessoa Canarias Las Palmas de Gran Canaria Spain"},{"name":"Mediteknia Dermatology Clinic Las Palmas de Gran Canaria Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-9358","authenticated-orcid":false,"given":"R.","family":"Paus","sequence":"additional","affiliation":[{"name":"Monasterium Laboratory M\u00fcnster Germany"},{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine Miami FL USA"},{"name":"Centre for Dermatology Research University of Manchester, and NIHR Biomedical Research Centre Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5927-6998","authenticated-orcid":false,"given":"M.","family":"Bertolini","sequence":"additional","affiliation":[{"name":"Monasterium Laboratory M\u00fcnster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"2023010800163941600_bjd20745-bib-0001","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2354.2001.00272.x","article-title":"Hair and cancer chemotherapy: consequences and nursing care \u2013 a literature study","volume":"10","author":"Batchelor","year":"2001","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2023010800163941600_bjd20745-bib-0002","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/bjd.12716","article-title":"Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study","volume":"170","author":"Kanti","year":"2014","journal-title":"Br J Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0003","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1007\/s00520-019-05284-0","article-title":"A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients","volume":"28","author":"Cong","year":"2020","journal-title":"Support Care Cancer"},{"key":"2023010800163941600_bjd20745-bib-0004","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jaad.2018.03.056","article-title":"Hair disorders in cancer survivors","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0005","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"2023010800163941600_bjd20745-bib-0006","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00520-009-0769-1","article-title":"Unanticipated toxicities from anticancer therapies: survivors' perspectives","volume":"18","author":"Gandhi","year":"2010","journal-title":"Support Care Cancer"},{"key":"2023010800163941600_bjd20745-bib-0007","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/ijd.13906","article-title":"Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review","volume":"57","author":"Rubio-Gonzalez","year":"2018","journal-title":"Int J Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0008","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2217\/fon-2019-0066","article-title":"Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia","volume":"15","author":"Orlando","year":"2019","journal-title":"Future Oncol"},{"key":"2023010800163941600_bjd20745-bib-0009","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2016.21038","article-title":"Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer","volume":"317","author":"Rugo","year":"2017","journal-title":"JAMA"},{"key":"2023010800163941600_bjd20745-bib-0010","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-018-4855-2","article-title":"Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling","volume":"171","author":"Mart\u00edn","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"2023010800163941600_bjd20745-bib-0011","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of chemotherapy-induced hair loss","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol"},{"key":"2023010800163941600_bjd20745-bib-0012","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.2353\/ajpath.2010.100454","article-title":"The pathogenesis of primary cicatricial alopecias","volume":"177","author":"Harries","year":"2010","journal-title":"Am J Pathol"},{"key":"2023010800163941600_bjd20745-bib-0013","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.molmed.2018.03.007","article-title":"Lichen planopilaris and frontal fibrosing alopecia as model epithelial stem cell diseases","volume":"24","author":"Harries","year":"2018","journal-title":"Trends Mol Med"},{"key":"2023010800163941600_bjd20745-bib-0014","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/exd.13846","article-title":"How chemotherapy and radiotherapy damage the tissue: comparative biology lessons from feather and hair models","volume":"28","author":"Gao","year":"2019","journal-title":"Exp Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0015","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaad.2009.08.024","article-title":"Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib","volume":"64","author":"Hepper","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0016","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2230.2010.03852.x","article-title":"Folliculitis decalvans associated with erlotinib","volume":"35","author":"Hoekzema","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0017","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1529-8019.2011.01430.x","article-title":"Treatment of chemotherapy-induced alopecia","volume":"24","author":"Yeager","year":"2011","journal-title":"Dermatol Ther"},{"key":"2023010800163941600_bjd20745-bib-0018","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamadermatol.2018.5071","article-title":"Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia","volume":"155","author":"Freites-Martinez","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0019","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1590\/abd1806-4841.20154013","article-title":"Clinical and histological study of permanent alopecia after bone marrow transplantation","volume":"90","author":"Basilio","year":"2015","journal-title":"An Bras Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bmt.1703695","article-title":"Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy","volume":"30","author":"de Jonge","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"2023010800163941600_bjd20745-bib-0021","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/annonc\/mds095","article-title":"Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients","volume":"23","author":"Kluger","year":"2012","journal-title":"Ann Oncol"},{"key":"2023010800163941600_bjd20745-bib-0022","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2353\/ajpath.2007.061164","article-title":"Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy","volume":"171","author":"Bodo","year":"2007","journal-title":"Am J Pathol"},{"key":"2023010800163941600_bjd20745-bib-0023","first-page":"719","article-title":"Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone","volume":"144","author":"Paus","year":"1994","journal-title":"Am J Pathol"},{"key":"2023010800163941600_bjd20745-bib-0024","first-page":"4438","article-title":"Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice","volume":"56","author":"Paus","year":"1996","journal-title":"Cancer Res"},{"key":"2023010800163941600_bjd20745-bib-0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.0022-202X.2005.23787.x","article-title":"A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice","volume":"125","author":"Hendrix","year":"2005","journal-title":"J Invest Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0026","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/JID.2015.358","article-title":"Development of a model for chemotherapy-induced alopecia: profiling of histological changes in human hair follicles after chemotherapy","volume":"136","author":"Yoon","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0027","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1038\/s41467-019-11665-0","article-title":"Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy","volume":"10","author":"Kim","year":"2019","journal-title":"Nat Commun"},{"key":"2023010800163941600_bjd20745-bib-0028","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM199908123410706","article-title":"The biology of hair follicles","volume":"341","author":"Paus","year":"1999","journal-title":"N Engl J Med"},{"key":"2023010800163941600_bjd20745-bib-0029","doi-asserted-by":"crossref","first-page":"R132","DOI":"10.1016\/j.cub.2008.12.005","article-title":"The hair follicle as a dynamic miniorgan","volume":"19","author":"Schneider","year":"2009","journal-title":"Curr Biol"},{"key":"2023010800163941600_bjd20745-bib-0030","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911031","article-title":"CDK4\/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia","volume":"11","author":"Purba","year":"2019","journal-title":"EMBO Mol Med"},{"key":"2023010800163941600_bjd20745-bib-0031","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaad.2016.12.027","article-title":"Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: clinicopathologic findings in a cohort of 10 patients","volume":"76","author":"Fonia","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0032","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1111\/jdv.16114","article-title":"Preclinical evidence that the PPARgamma modulator, N-Acetyl-GED-0507-34-Levo, may protect human hair follicle epithelial stem cells against lichen planopilaris-associated damage","volume":"34","author":"Cheret","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023010800163941600_bjd20745-bib-0033","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/exd.14062","article-title":"PPAR-gamma signalling as a key mediator of human hair follicle physiology and pathology","volume":"29","author":"Ramot","year":"2020","journal-title":"Exp Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0034","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jid.2017.09.047","article-title":"Epithelial-to-mesenchymal stem cell transition in a human organ: lessons from lichen planopilaris","volume":"138","author":"Imanishi","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0035","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.jid.2018.01.033","article-title":"Peroxisome proliferator-activated receptor-gamma-mediated signaling regulates mitochondrial energy metabolism in human hair follicle epithelium","volume":"138","author":"Ramot","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0036","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12647","article-title":"The role of PPARgamma-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology","volume":"24","author":"Ramot","year":"2015","journal-title":"Exp Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0037","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/jid.2013.473","article-title":"Advanced inhibition of undesired human hair growth by PPARgamma modulation?","volume":"134","author":"Ramot","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0038","doi-asserted-by":"crossref","first-page":"S-515","DOI":"10.1016\/S0016-5085(11)62136-7","article-title":"Preclinical evaluation of intestinal anti-inflammatory\/analgesic properties and phase I clinical trial of a new PPAR agonist Ged-0507-34-Levo","volume":"140","author":"Rousseaux","year":"2011","journal-title":"Gastroenterology"},{"key":"2023010800163941600_bjd20745-bib-0039","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ics.12521","article-title":"Transepidermal UV radiation of scalp skin ex vivo induces hair follicle damage that is alleviated by the topical treatment with caffeine","volume":"41","author":"Gherardini","year":"2019","journal-title":"Int J Cosmet Sci"},{"key":"2023010800163941600_bjd20745-bib-0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/exd.12836","article-title":"Human hair follicle organ culture: theory, application and perspectives","volume":"24","author":"Langan","year":"2015","journal-title":"Exp Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0041","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0625.2006.00510.x","article-title":"Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions","volume":"16","author":"Lu","year":"2007","journal-title":"Exp Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0042","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0625.2009.00939.x","article-title":"Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture","volume":"19","author":"Kloepper","year":"2010","journal-title":"Exp Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0043","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4161\/cbt.12.6.15956","article-title":"The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells","volume":"12","author":"Wilson","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"2023010800163941600_bjd20745-bib-0044","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cells8101118","article-title":"The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges","volume":"8","author":"Loh","year":"2019","journal-title":"Cells"},{"key":"2023010800163941600_bjd20745-bib-0045","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1111\/j.1600-0625.2009.01009.x","article-title":"A simple assay for the study of human hair follicle damage induced by ionizing irradiation","volume":"19","author":"Poeggeler","year":"2010","journal-title":"Exp Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0046","first-page":"5002","article-title":"p53 is essential for chemotherapy-induced hair loss","volume":"60","author":"Botchkarev","year":"2000","journal-title":"Cancer Res"},{"key":"2023010800163941600_bjd20745-bib-0047","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jid.2020.05.118","article-title":"Inhibition of Shh signaling through MAPK activation controls chemotherapy-induced alopecia","volume":"141","author":"Haslam","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0048","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12906-020-03025-z","article-title":"Human placenta induces hair regrowth in chemotherapy-induced alopecia via inhibition of apoptotic factors and proliferation of hair follicles","volume":"20","author":"Kim","year":"2020","journal-title":"BMC Complement Med Ther"},{"key":"2023010800163941600_bjd20745-bib-0049","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jid.2015.12.021","article-title":"p53 is a direct transcriptional repressor of keratin 17: lessons from a rat model of radiation dermatitis","volume":"136","author":"Liao","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152439","article-title":"LCZ696 (sacubitril\/valsartan) protects against cyclophosphamide-induced testicular toxicity in rats: Role of neprilysin inhibition and lncRNA TUG1 in ameliorating apoptosis","volume":"437","author":"Salama","year":"2020","journal-title":"Toxicology"},{"key":"2023010800163941600_bjd20745-bib-0051","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI27490","article-title":"Gene expression profiling gets to the root of human hair follicle stem cells","volume":"116","author":"Cotsarelis","year":"2006","journal-title":"J Clin Invest"},{"key":"2023010800163941600_bjd20745-bib-0052","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2010.03.020","article-title":"Permanent chemotherapy-induced alopecia: a review","volume":"64","author":"Palamaras","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2023010800163941600_bjd20745-bib-0053","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14740338.2017.1343299","article-title":"Treatment options for nonalcoholic steatohepatitis \u2013 a safety evaluation","volume":"16","author":"Issa","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"2023010800163941600_bjd20745-bib-0054","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41416-019-0520-8","article-title":"Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines","volume":"121","author":"Munzone","year":"2019","journal-title":"Br J Cancer"},{"key":"2023010800163941600_bjd20745-bib-0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.2016.20939","article-title":"Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial","volume":"317","author":"Nangia","year":"2017","journal-title":"JAMA"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.20745","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.20745","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/186\/1\/129\/47428290\/bjd0129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/186\/1\/129\/47428290\/bjd0129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:06:42Z","timestamp":1676383602000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/186\/1\/129\/6593655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,1]]},"published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.20745","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2022,1,1]]},"assertion":[{"value":"2021-08-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}